Search

everythinglearnresearchcommunity

for

Search:↓

A rare case of a transplant patient developing a skin condition linked to HPV-49.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Gefitinib can cause scalp skin issues and permanent hair loss.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Naltrexone shows promise as a safe treatment for a type of hair loss called lichen planopilaris.

Centella asiatica with growth factors improves hair and scalp health.

Localized estrogen treatments may improve skin quality with fewer risks than systemic hormone therapy.

Early recognition of symptoms is crucial for treating IPEX syndrome with a stem cell transplant.

Tofacitinib might be used to treat hair loss.

MVP treatment is effective and safe for recurrent breast cancer.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Seresto® collar is safe to use with Advocate® and Profender® on dogs and cats.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

The man's scalp condition improved significantly with daily use of 0.1% mometasone furoate cream.

VDDR I and II are genetic disorders affecting vitamin D use, causing rickets, with VDDR I treatable by vitamin D supplements and VDDR II needing high doses and calcium.

Most emerging dermatological treatments lack strong evidence and require more research.

The document suggests changing "Follicular Unit Extraction" to "Follicular Unit Excision" to more accurately describe the surgical hair transplant procedure.

A Chinese family had a child with a specific gene mutation causing vitamin D-resistant rickets, but the child improved with calcium and low-dose calcitriol.

Adipose stem cell exosomes can effectively reduce facial redness and improve skin health in atopic dermatitis patients.

ERK activation spreads between cells in mouse skin, linked to cell division and influenced by TPA and EGF receptors.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Brodalumab is more effective than ustekinumab in treating psoriasis.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Using cetirizine on the skin and taking vitamin D can help increase hair growth in children with hair loss from ectodermal dysplasia.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Eruptive vellus hair cysts are rare, benign skin lesions that are hard to treat.

Applying a special soy milk extract on skin can make it more elastic and hydrated.